The short-term efficacy and safety of faricimab in refractory neovascular age-related macular degeneration- the real-world experience in Taiwan.

Sheng-Chu ChiChang-Chi WengShih-Jen ChenTai-Chi LinYu-Bai ChouDe-Kuang Hwang

Published in: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (2024)

Faricimab showed favorable outcomes in refractory nAMD patients. Further investigations are needed to understand factors contributing to its efficacy.

Keyphrases

age related macular degeneration
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
type diabetes
adipose tissue
metabolic syndrome
patient reported outcomes